Skip to content

Martine A Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS, sold UTHR on Sep 30, 2026

Data as of Oct 16

▼ SELL$154K280 shares at $548.25Martine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp
Watch UTHR
Traded
Sep 30, 2026
Disclosed
Oct 1, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Martine A Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS, sold UTHR on Sep 30, 2026TRADEDDISCLOSED
UTHRSimilar stocks (XLV — its sector index fund), rebased to UTHR's price on the disclosure day
UTHR since disclosure
−6.7%
after the sale
Similar stocks (XLV) since disclosure
+6.3%
XLV — its sector index fund

Change in closing price from Oct 1, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$220Kdisclosed Oct 1 · filed 1 day after the trade
  2. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$88.2Kdisclosed Oct 1 · filed 1 day after the trade
  3. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$219Kdisclosed Oct 1 · filed 1 day after the trade
  4. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$115Kdisclosed Oct 1 · filed 1 day after the trade
  5. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$66.3Kdisclosed Oct 1 · filed 1 day after the trade
  6. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$132Kdisclosed Oct 1 · filed 1 day after the trade
  7. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$62.6Kdisclosed Oct 1 · filed 1 day after the trade

See every trade on UTHR →